Drug recall D-0559-2024
Product
Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03
Reason for recall
Failed Content Uniformity Specifications
Lots and codes
Lot F201519, Expiry: November 2024
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 3,552 bottles
- Distribution
- Nationwide in the US
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 30, 2024
- Terminated
- April 29, 2025
Related products
- Cefixime – drug information
- NDC 68180-423 Cefixime · Cefixime 400 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-405 Cefixime · Cefixime 100 mg/5mL · Lupin Pharmaceuticals, Inc.
- NDC 68180-407 Cefixime · Cefixime 200 mg/5mL · Lupin Pharmaceuticals, Inc.